日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

基于定量模型的米尔维西恩III期临床试验剂量选择研究(针对房颤患者)

Zhou, Wangda; Bozenhardt, Emily; Alexander, Gregory E; Zierhut, Matthew L; Merali, Samira; Ajavon-Hartmann, Antoinette; Zannikos, Peter; Back, Hyunmoon; Suh, EunYoung; Goyal, Navin; Samtani, Mahesh N; Plotnikov, Alexei N; Valiathan, Chandni

Analysis of the measurements used as potency tests for the 31 US FDA-approved cell therapy products

对用于31种美国FDA批准的细胞治疗产品效力测试的测量方法进行分析

Simon, Carl G Jr; Bozenhardt, Erich H; Celluzzi, Christina M; Dobnik, David; Grant, Melanie L; Lakshmipathy, Uma; Nebel, Thiana; Peltier, Linda; Ratcliffe, Anthony; Sherley, James L; Stacey, Glyn N; Taghizadeh, Rouzbeh R; Tan, Eddie H P; Vessillier, Sandrine

Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis

在针对中重度银屑病患者的IIb期研究中,Icotrokinra可诱导早期且持续的药效学反应。

Strawn, David; Krueger, James G; Bissonnette, Robert; Eyerich, Kilian; Ferris, Laura K; Paller, Amy S; Pinter, Andreas; Richards, Dylan; Chen, Elizabeth Y; Paget, Kate; Horowitz, Daniel; Parast, Roohid; Rusbuldt, Joshua J; Sendecki, Jocelyn; Bhagat, Sunita; Tomsho, Lynn P; Chou, Ching-Heng; Polak, Marta E; Keyes, Brice E; Bozenhardt, Emily; Xiong, Yuan; Zhou, Wangda; DeKlotz, Cynthia; Newbold, Paul; Waterworth, Dawn M; Miller, Megan; Ota, Takayuki; Yang, Ya-Wen; Leung, Monica Wl; Miller, Lloyd S; Cuff, Carolyn A; McRae, Bradford; Ruane, Darren; Kannan, Arun K

Mechanism of action, potency and efficacy: considerations for cell therapies

作用机制、效力和功效:细胞疗法的考量

Simon, Carl G Jr; Bozenhardt, Erich H; Celluzzi, Christina M; Dobnik, David; Grant, Melanie L; Lakshmipathy, Uma; Nebel, Thiana; Peltier, Linda; Ratcliffe, Anthony; Sherley, James L; Stacey, Glyn N; Taghizadeh, Rouzbeh R; Tan, Eddie H P; Vessillier, Sandrine